Reproductive endocrinology

Classes and predictors of reversal in male patients with congenital hypogonadotropic hypogonadism: a cross-sectional study of six international referral centres

Lancet Diabetes EndocrinolPublished Cross-sectional study

Authors' conclusion

Applying LCMM to a large cohort of male patients with CHH reversal uncovered two distinct classes of reversal. Genetic investigation combined with careful clinical phenotyping could help surveillance of reversal after withdrawing treatment, representing the first tailored management approach for male patients with this rare endocrine disorder.

Study context

Population
Adult men with congenital hypogonadotropic hypogonadism (CHH) (absent or incomplete spontaneous puberty by age 18 years, low serum testosterone, no identifiable cause of HPG axis dysfunction), referral centres in Brazil, Finland, France, Italy, the UK and the USA
Participants
75 / 12 / 87 / 108
Exposure
CHH reversal vs no CHH reversal; reversal class 1 vs class 2
  • Class 1n = 75reference
  • Class 2n = 12
  • CHH reversaln = 87
  • Without CHH reversaln = 108reference
Outcome
Presence of at least two distinct classes of reversal
Methodological detailsmulticentre, six international CHH referral centres, latent class mixture modelling
  • Multicentre
  • Six international CHH referral centres
  • Latent class mixture modelling

Main finding

As reported in the abstract

Distinct reversal classes (LCMM)
GroupValueClassification probability
Class 186%0.998
Class 214%0.838

Value

Class 186%
Class 214%

Classification probability

Class 10.998
Class 20.838
Entropy (modelling uncertainty low)
0.90

Observational data: associations, not effects.

Further findings

OutcomeCHH reversalWithout CHH reversalP value
Rare pathogenic ANOS1 variant (genetically tested)0 events11%
Tested7595
Rare variants in GNRHR (genetically tested)CHH reversal vs Without CHH reversal · significantly higher with CHH reversal12%3%P = 0.025
Tested7595
Class 2 vs class 1 phenotype · significantly larger with class 2
P < 0.0001
Class 2 vs class 1 phenotype · higher with class 2
P = 0.041
Predictors: features more likely without CHH reversal · Without CHH reversal vs CHH reversal · more likely without reversal
P = 0.016
Predictors: features more likely without CHH reversal · Without CHH reversal vs CHH reversal · more likely without reversal
P = 0.0012
Predictors: features more likely without CHH reversal · Without CHH reversal vs CHH reversal · more likely without reversal
P = 0.0016
Predictors: features more likely without CHH reversal · Without CHH reversal vs CHH reversal · more likely without reversal
P = 0.0001

Class 2 vs class 1 phenotype

No micropenis in class 2; consistent with Pasqualini syndrome (fertile eunuch) subtype

Original publication

Classes and predictors of reversal in male patients with congenital hypogonadotropic hypogonadism: a cross-sectional study of six international referral centres. Lancet Diabetes Endocrinol. Published 1 March 2024. doi:10.1016/s2213-8587(24)00028-7

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.